The bc-GenExMiner analysis of 5277 BC samples Jézéquel et al., 2013 demonstrated tight co-expression of EHD2 with the structural components of caveolae, CAV1 and CAV2 in TNBC samples (Figure 7A, Figure 7—figure supplement 1A). Here, EHD2 is linked to breast cancer.